NICE· @NICEComms · X·· 6 天前精选AI 评分50
AI 导读
NICE 已推荐 nirogacestat，为罕见硬纤维瘤患者提供 NHS 治疗选择，这是该机构针对这一非癌性病症推荐的首个靶向治疗。更多信息见 NICE 指南页面。
推荐理由
NICE 推荐 nirogacestat 用于罕见硬纤维瘤，读者可了解该靶向治疗在 NHS 体系中的准入定位。
正文
An NHS treatment option is now available for people with rare desmoid tumours.
NICE has recommended nirogacestat, the first targeted treatment we’ve recommended for this non-cancerous condition.
Find out more: https://www.nice.org.uk/guidance/indevelopment/gid-ta11559/documents?utm_medium=organic&utm_source=x&utm_campaign=nirogacestat_240926&utm_content=graphic
来源：NICE · x.com